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ABSTRACT 
Objective: The resistance to β-lactam antibiotics is a serious problem worldwide. This resistance has emerged due to two main mechanisms: 
production of β-lactamases that hydrolyses β-lactam antibiotics and other is the production of low affinity mutated Penicillin Binding Proteins 
(PBPs) that can sustain even at the high concentration of antibiotics. The current study epitomises the identification of T(425)S mutations in PBP4 
of β-lactam resistant Enterococcus faecalis isolated from uropathological samples of urinary tract infected (UTI) patients. Also, the effect of the this 
mutation was analysed by in silico strategies on ligand binding efficiencies of the active site of PBP4 towards selected β-lactam antibiotics as well as 
phytochemicals.  
Methods: To study the effect of T(425)S mutation towards emergence of antibiotic resistance pattern, the structural model was generated for wild-
type and mutated PBP4 of E. faecalis using MODELLER and further studied the interactions of PBP4 with β-lactam antibiotics along with various 
phytochemicals identified and purified from selected medicinal plants possessing antibacterial activity using Autodock4 suite.  
Results: Based on the results of different docking parameters and a number of H-bond interactions, gallic acid, and quercetin were identified with 
highest binding affinity to the active site pocket of PBP4 of E. faecalis, compared to β-lactam antibiotics. Further, molecular simulation studies also 
supported this fact.  
Conclusion: T (425)S mutation has been identified with a significant change in ligand binding efficiencies towards tested β-lactam antibiotics. 
Moreover, gallic acid and quercetin have showed the possible antibacterial agent via blocking the active site of PBP4 of E. faecalis. The results 
presented here could be useful in designing more effective phyto-ligands based therapeutic antibacterial compounds against PBP4 of E. faecalis. 
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INTRODUCTION 
Enterococci are normal human inhabitants of the gastrointestinal 
tract, however, they are also categorised as pathogens responsible 
for causing a wide variety of infections to humans [1]. Enterococcus 
faecalis caused 80-90% enterococcal infections while Enterococcus 
faecium accounted for 5-10% [1]. Both strains have been identified as 
emerging β-lactam resistant. Moreover, among UTI causing 
enterococci, multi-drug resistant E. faecalis such as vancomycin-
resistant strains (VRE) have been reported increasingly in many 
countries [2]. 
The important mechanisms reported for the development of β-
lactam resistance in E. faecalis are β-lactamase production, 
overproduction of PBP4 or PBP5 and decreased affinity for β-lactam 
antibiotics by point mutations in penicillin binding domains of PBPs 
[2]. Penicillin-binding proteins or PBPs are crucial bacterial enzymes 
that catalyse the synthesis of the cell wall, an important constituent, 
essential for their survival and reproduction [3, 4]. 
The urinary tract infections (UTIs) are among the very common 
infectious diseases occurring publicly. In spite of an enormous 
success of antibiotics as antibacterial agents, the widespread and 
uncontrolled use of antibiotics has led to the emergence of 
multidrug-resistant (MDR) bacteria. “Antibiotic Resistance” is the 
ability of the bacteria to multiply continuously in the presence of 
antibacterial agents, even in the presence of high concentration [5]. 
As antimicrobial resistance is increasing day by day leaving limited 
treatment options, it is essential to study the antibiotics resistance 
pattern among the bacteria to prescribe correct and effective 
antibiotics.  
As bacteria have emerged multidrug resistant (MDR), that has put all 
human beings with a risk of limited treatment options along with 
increased mortality. Hence, there is an urgent need to search for a 
new antibacterial agent. Moreover, the medicinal plants have been 
used since ancient times for the treatment of various infectious 
diseases worldwide. The potent antibacterial phyto constituents were 
identified and purified from the medicinal plants against E. faecalis. 
Detailed analysis was performed for a better understanding of the 
molecular interactions between the ligands and target PBP4 (wild type 
and mutant) of E. faecalis with the help of in silico molecular docking 
tools. The molecular docking programs usually used to establish new 
ligands/inhibitors for the selected target receptor protein from the 
different available databases based on their efficiency to bind the 
active sites on the receptor. The docking exhibited different binding 
poses out of which the one with minimum binding energy was 
selected. The favourable conformation was analysed with hydrogen 
bonding with the active site residues of PBP4.  
MATERIALS AND METHODS 
Isolated strains from clinical urine specimens 
In total, 100 urine samples were collected from the suspected UTI 
patients from different pathology labs in Nagpur region, 
Maharashtra, India. It was observed that 86% of collected urine 
samples were UTI positive, and 35.16% of the patients were found 
to be infected with E. faecalis, confirmed with 16s rRNA sequencing. 
Antibiotic sensitivity 
The antibiotic sensitivity for isolated E. faecalis was checked for 
following β-lactam antibiotics using 4X-concentration of reported 
MIC (minimum inhibitory concentration) by Kirby-Bauer method 
[6]. The β-lactam antibiotics used were Cefpodoxime (16µg), 
Cephalexin (4.0µg), Cefuroxime (16µg), Cefixime (4.0µg), Ceftazidime 
(2.0µg), Cefazoline (4.0µg), Cefotaxime (32µg), Ceftriaxome (2.0µg), 
Cefaclor (32µg), Feropenem (8.0µg) and Cefepime (32µg). The β-
lactam resistant E. faecalis strains were selected for further 
molecular analysis. 
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Amplification and sequencing of PBP4 of E. faecalis 
PBPs are encoded by the bacterial genomic DNA (gDNA). The gDNA 
was extracted using following method: The bacterial cells were 
pelleted by centrifugation at 3000rpm for 5 min and washed with 
milliQ water. The pellet was suspended in water and boiled for 10 
min at 100 °C. This lysate was centrifuged, and the supernatant was 
collected. This supernatant was used directly as a template for the 
amplification of PBP4. The primer set used were Forward (5’-CTG 
TGG ATA CTC TCC CGC AC-3’) and Reverse (5’-CAG CAG AAT ACC 
CAC CAG CA-3’). Thermal cycler (PeqLab) was used to amplify PBP4 
under following conditions: Initial denaturation at 95ºC for 5 min, 
followed by 30 cycles of 1 min at 94ºC, 1 min of annealing at 52.2ºC 
and 1.5 min at 72ºC and finally 10 min at 72ºC. PCR amplicons were 
detected electrophoretically in 1% agarose gel using 1X TAE, 
visualized by staining with 0.5 µg/ml ethidium bromide, examined in 
UV light and photographed by Molecular Imager Gel Doc XR (Biorad 
Laboratories). 
DNA sequencing for mutational analysis 
Amplified PCR products were purified using Qiagen purification kit 
(Germany) and bidirectional sequencing was outsourced to Xceleris 
Labs, India. The mutations were analysed with public access 
software (www.ncbi.nlm.nih.gov). Also, the data was analysed with 
Chromuslite, SIFT and PROVEAN PROTEIN. 
Phytochemical extraction, purification, and identification 
The antibacterial activity was studied in the crude extract of 
Andrographis paniculata Burm. f. Wall. Ex. Nees (Ap), Astercantha 
longifolia (L.) Nees (Al), Bixa orellana L. (Bo), Gardenia resinifera 
Roth, (Gr), Pongamia pinnata (L.) Pierre (Pp), Psoralea corylifolia L. 
(Pc), Sphaeranthus indicus Linnaeus (Si), Solanum trilobatum L. (St), 
Soyamida febrifuga (Roxb.) Juss (Sf) and Thespesia populnea (L.) Sol. 
Ex. Correa (Tp). These plants were collected from Nagpur city, 
Maharashtra, India. All plants were identified by a taxonomist at the 
Department of Botany, Rashtrasant Tukadoji Maharaj Nagpur 
University, Nagpur. The herbarium were deposited in the 
department of botany with the following voucher numbers 9038 
(Andrographis paniculata), 9039 (Astercantha longifolia), 9041 (Bixa 
orellana), 10012 (Gardenia resinifera), 10037 (Pongamia pinnata), 
10038 (Psoralea corylifolia), 10039 (Sphaeranthus indica), 10041 
(Solanum trilobatum), 10042 (Soyamida febrifuga) and 10043 
(Thespesia populnea). 
These plants have shown a significant antibacterial activity against 
isolated MDR E. faecalis and hence the phytochemicals were 
extracted from these medicinal plants by Soxhletion (hot extraction) 
and cold maceration for analysis of antibacterial compounds. It was 
observed that the phytochemicals extracted through cold 
maceration using 50% aqueous methanol (V/V) showed significant 
phytochemicals yield and highest antibacterial activity against MDR 
E. faecalis isolates compared to the Soxhlet extracts. Hence, the cold 
extracts of all plants were used for HPLC analysis [7] to identify and 
purify the probable phytoconstituents accountable for giving the 
antibacterial activity by Reverse phase C-18-aminopack zorbax 
eclipse-AAA column with SPD 10 AVP pump. Methanol: water (90:10 
v/v) was utilized as the mobile phase.  
In silico studies 
In silico studies by molecular docking is an important tool to 
study the interaction of ligands with active site residues of the 
receptor [8, 10]. The docking involves the use of sampling 
algorithm and a scoring function to evaluate the proper 
orientation and pose of ligand molecule in relation to the binding 
energy. The correct identification of this binding pose of one or 
more related ligands is important in establishing a structure-
activity relationship in lead optimization. The second use of 
scoring functions is to rank different ligands to predict their 
relative experimental activity [10-12]. 
The molecular docking simulations were carried out using Windows 
8,1 professional, 64 bit Intel core M-5Y10c CPU at 1.00 GHz, 4 GB 
RAM) using the Auto dock program (v1.5.6) which defines the 
binding site in terms of grid of interaction points, structural 
homology models were generated for mutant protein by Modeller, 
simulation, and salvation studies were carried out by Gromacs.  
Ligand preparation 
The phytochemicals that exhibited prominent antibacterial activity 
towards isolated multidrug-resistant bacteria were selected for 
molecular docking analysis. The structure of these phytochemicals 
was downloaded from PubChem online portal and drawn in 
Chemsketch. For auto dock tool, all ligand molecules were in PDB 
format, hence these drawn ligand structures in MDL-mol format 
were converted to pdb format by Open Babel GUI software. 
Homology model generated for PBP4 
The biological crystal structure of PBP4 is still not available on 
protein data bank (PDB); hence to get structural information the 
homology model was generated for both wild type and mutant 
protein using Modeller, Swiss model and Phyre2. PBP4 was found to 
have 36% identities and 56% positives with PBP2a from methicillin-
resistant Staphylococcus aureus (PDB ID: 1VQQ_A) with resolution 
1.8A ° and this structure was used for the preparation of model for 
pbp4 of E. faecalis. The prepared models were further validated by 
Ramachandran plot with the help of PROCHECK and the best model 
was used for energy minimization and optimisation by SPDBV. 
Gromacs was used to analyse the energy minimization and Procheck 
was used to study the Ramachandran plot of minimised structure. 
These models were used further to analyse and compare the effect of 
the mutation on the binding efficiency of PBP4 towards different β-
lactam antibiotics as well as purified phytochemicals.  
Virtual screening by Auto Dock  
The catalytically important serine residue of the active site of PBP4-
Ser (232) was defined as the center of the grid with grid box 
60×60×60A ° having a grid spacing of 0.375A °, which covered all the 
active site residues and allowed flexible rotation of the ligand. The 
number of generations, energy evaluations, and individuals in the 
population are set to 27000, 5×106, and 150 respectively. The 
Lamarckian genetic algorithm was adopted for sampling ligand 
conformations.  
The default parameters of free energy scoring function were used 
for the docking studies. The best scoring and lowest RMSD solutions 
from 50 runs were considered as the predicted binding conformers. 
The RMSD values of each docked conformer were calculated from 
the corresponding crystal structure as a reference to access the 
accuracy of poses with respect to their binding energy. The H-bond 
interactions were analysed in Chimera. 
RESULTS  
The β-lactam resistant E. faecalis isolates 
It was found that 35% of the UTI patients were infected with multi 
drug resistant E. faecalis. The other predominant bacteria isolated 
were E. coli (26%) and Pseudomonas aeruginosa (36%). E. faecalis 
were found highly resistant to Cephalexin (1μg) followed by 
Cefpodoxime (16µg) Cefotaxime (32µg). Also, they showed emerging 
resistant towards other tested β-lactam antibiotics.  
PCR amplification of pbp4 
The PCR amplification of PBP-4 gene in E. faecalis was standardised at 
52.2 °C primer annealing temperature. The amplification was seen in 
five isolates. E. faecalis strains numbers that showed amplifications 
were 3, 5, 6, 9 and 30 (data shown in the following fig.). 
Mutation in PBP-4 of E. faecalis 
The point mutation observed in PBP-4 was T(425)S which means 
that, at position 425, Threonine (T) was replaced by Serine (S). 
These sequence data have been submitted to NCBI gene bank and 
following accession numbers have been allotted. 
Purified phytochemicals by HPLC 
The following phytochemicals were identified and purified by HPLC 
as described in fig. and table. 
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Fig. 1: Amplification of PBP-4from E. faecalis on 1%agarose gel 
 
Table 1: Accession numbers for E. faecalis MDR isolates 
S. No. E. faecalis MDR isolate number Accession number 
1 EF 2 KR422418 
2 EF 5 KR422419 
3 EF 6 KR422420 
4 EF 9 KR422421 
5 EF 30 KR422422 
□ EF: Enterococcus faecalis 
 
 
Fig. 2: HPLC chromatogram of phytochemicals 
 
Table 2: Identified phytochemicals by HPLC 
S. No. Retention time in min Peak area Phytochemical 
1 1.25 625 Tannic acid 
2 4.44 854 Ellagic acid 
3 3.02 958 Quercetin 
4 10.02 758 Chlorogenic acid 
5 15.00 1235 2-Furaldehyde,5 (hydroxy methyl) 
6 3.89 558 Naringenin 
7 10.98 501 Theophylline 
8 5.82 425 Betulinic acid 
9 12.50 1001 Resorcinol 
10 7.48 1001 Catechol 
11 17.50 1123 Salicylic acid 
12 8.54 625 Vanillin 
13 16.23 1234 Hexadecanoic acid 
14 13.02 526 3-o-methyl glucose 
15 4.62 802 Gallic acid 
16 8.95 596 Squalene 
17 14.25 977 Pyrogallol 
 
Antibacterial activity of phytochemicals 
The antibacterial potency of these purified phytochemicals has been 
analysed, as described in the following table. 
Structure model for wild-type and mutant PBP4 
After the homology search, PBP4 of E. faecalis was found to have 
36% identities and 56% positives with the crystal structure of 
PBP2a of methicillin-resistant Staphylococcus aureus (PDB ID: 
1VQQ_A) with resolution 1.8A°. Based on the available structure 
information of PBP2a of S. aureus, it was used as a template and 
homology model was generated for Wild type and mutant PBP4 of E. 
faecalis as shown in the following fig. 
The prepared chimera model for pbp4 of E. faecalis was validated by 
Ramachandran plot. The amino acids found in the white area were 
PRO 602, ASP 81, ASP 159, ASP 630, ILE 507 and few Glycine. These 
amino acids were not interfering with the substrate binding region, 
but the structure was refined further. 
Ligand docking and binding energy calculations for PBP4 
The comparative analysis of ligand binding energy for wild-type and 
mutant PBP4 is shown in the following table: 
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Table 3: Zone of inhibition (mm) for phytochemicals against MDR E. faecalis 
S. No. Phytochemical (1μg) Antibacterial activity 
Zone of inhibition (mm) 
Mean  
1. Catechol 16  
2. Chlorogenic acid 14  
3. Ellagic acid 10  
4. Gallic acid 19  
5. Naringenin 14  
6. Pyrogallol 12  
7. Quercetin 17  
8. Resorcinol <10  
9. Salicylic acid 17  
10. Tannic acid 20  
11. Theophylline 14  
12. Vanillin 16  
 Data represents mean of triplicate 
 
Table 4: Comparative analysis of ligand binding energy for wild type and mutant PBP4 
Ligands Minimum binding energy (Kcal/mol) 
Wild type PBP4 Mutant PBP4 
Chlorogenic acid -42.742 -43.589 
Quercetin -43.921 -47.396 
Cephalosporin -31.662 -29.874 
Methicillin -30.859 -29.114 
Bocillin -41.082 -38.112 
Penicillin -37.712 -37.643 
Mezlocillin -38.551 -32.767 
Ampicillin -36.433 -35.116 
Ellagic acid -35.884 -35.731 
Naringenin -40.117 -39.792 
Gallic acid -49.512 -41.766 
Pyrogallol -33.129 -24.458 
Amoxicillin -30.131 -28.747 
Catechol -30.794 -30.721 
Vanillin -21.089 -32.299 
Salicylic acid -29.254 -29.391 
Theophylline -19.006 -19.203 
Resorcinol -28.741 -28.796 
The interactions of two standard antibiotics, cephalosporin, and penicillin along with two phytochemicals with highest binding affinity, gallic acid 
and quercetin are shown in the following table. 
 
Table 5: Interaction of ligand with active site residues of wild type and mutant PBP4 
Ligand Interaction of ligand with wild-type PBP4 Interaction of ligand with mutant PBP4 
Penicillin ASN 163 (H-bond, 1.86447A °) 
ASN 163 (H-bond, 2.24557A °) 
ASN 78 (H-bond, 1.88405A °) 
LYS 88 (H-bond, 2.2124A °) 
LYS 88 (π-cation, 4.82044A °) 
LYS 88 (H-bond, 2.21943A °) 
ASN 78 (H-bond, 1.86247A °) 
ASN 163 (H-bond, 2.10571A °) 
ASN 163 (H-bond, 2.12828A °) 
Cephalosporin LYS 88 (Salt bridge, 2.92706A °) 
LYS 88 (Salt bridge, 4.36444A °) 
ASN 163 (H-bond, 2.07318A °) 
LYS 88 (H-bond, 1.952A °) 
ASP 164 (H-bond, 2.48168A °) 
ASP 326 (H-bond, 1.71764A °) 
ASP 164 (H-bond, 1.54807A °) 
ASP 325 (H-bond, 1.78339A °) 
LYS 77 (H-bond, 1.77396A °) 
LYS 152 (H-bond, 1.63866A °) 
LYS 152 (Salt bridge, 4.33472A °) 
SER 161 (H-bond, 2.58339A °) 
Quercetin LYS 88 (π-cation, 3.78364A °) 
ASP 326 (H-bond, 2.55525A °) 
ILE 166 (H-bond, 1.90599A °) 
ASN 78 (H-bond, 2.23008A °) 
ASP 326 (H-bond, 1.74624A °) 
LYS 88 (π-cation, 3.83474A °) 
ASN 78 (H-bond, 2.03053A °) 
LYS 77 (H-bond, 1.91414A °) 
ASN 163 (H-bond, 2.31256A °) 
Gallic acid ASP 164 (H-bond, 1.88277A °) 
ASP 164 (H-bond, 1.87262A °) 
LYS 88 (π-cation, 4.18453A °) 
ASP 164 (H-bond, 1.66558A °) 
ASP 164 (H-bond, 1.93206A °) 
LYS 88 (π-cation, 4.4133A °) 
 
From above docking analysis, it has been observed that T(425)S 
point mutation in E. faecalis has changed its antibiotic affinity 
towards β-lactam antibiotics. The minimum binding energy required 
to bind the active site of PBP4 has increased for cephalosporin, 
methicillin, ampicillin and amoxicillin. This means the affinity to bind 
the active site has been decreased after mutation, and it could be one 
of the possible reasons to develop resistance or increased MIC 
towards these antibiotics. 
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Fig. 3: Chimera model for wild type PBP4 of E. faecalis and its ramachandran plot 
 
On the other hand, compared to these β-lactam antibiotics, gallic 
acid and quercetin have showed very less binding energy in wildtype 
and mutant form. This docking analysis opens new avenues to 
design and synthesise new antibacterial agent based on 
phytoconstituents structures, especially gallic acid, and quercetin. 
DISCUSSION 
Many researchers have shown the emergence of multidrug 
resistance in Enterococci faecalis to all clinically useful antibiotics 
[13] and in the current study, it was identified that E. faecalis have 
developed resistance towards 3rd
It is clear from molecular docking analysis that T(425)S point 
mutation of pbp4 in E. faecalis has decreased the binding affinity for 
cephalosporin, penicillin, methicillin, ampicillin, amoxicillin.  
Moreover, the phytochemicals with antibacterial activity were 
analysed for their binding efficiency to the active site of pbp4 of E. 
faecalis. Among all tested phytochemicals, gallic acid and quercetin 
were found with highest binding affinity to the ligand binding pocket 
of pbp4 of E. faecalis than tested β-lactam antibiotics. Hence, gallic 
acid and quercetin could be possible antibacterial agents for PBP4 
mediated multidrug resistance of E. faecalis. More studies on 
molecular dynamics and simulation are needed for corroborating 
the role of quercetin and gallic acid as antibacterial agents to treat 
MDR E. faecalis mediated uropathological infections. 
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